GlycoMimetics, Inc. (GLYC) by event type
GLYC moves most on analyst downgrades — a median of +0.66% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the GLYC overview →
How GLYC reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 270 of 2,603 | 10 | +0.66% | 60% | -1.78% |
| Coverage initiations 1,104 of 2,283 | 55 | 0.00% | 47% | -0.60% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how GLYC usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · GLYC overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) | 145 | 0.00% | 46% |
| Oramed Pharmaceuticals Inc. (ORMP) | 145 | +0.69% | 69% |
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.